60 | Jahresbericht 2021 | Medizinische Klinik 2 1. Ammon F, Moshage M, Smolka S, Goeller M, Bittner DO, Achenbach S, Marwan M. Influence of reconstruction kernels on the accuracy of CT-derived fractional flow reserve. Eur Radiol. 2021 Nov 4. Epub ahead of print. 2. Andonian CS, Freilinger S, Achenbach S, Ewert P, Gundlach U, Hoerer J, Kaemmerer H, Pieper L, Weyand M, Neidenbach RC, Beckmann J. ‚Well-being paradox‘ revisited: a cross-sectional study of quality of life in over 4000 adults with congenital heart disease. BMJ Open. 2021 Jun 22; 11(6):e049531. 3. Andonian C, Freilinger S, Achenbach S, Ewert P, Gundlach U, Kaemmerer H,Nagdyman N, Neidenbach RC, Pieper L, Schelling J, Weyand M, Beckmann J. Quality of life in patients with Marfan syndrome: a cross-sectional study of 102 adult patients. Cardiovasc Diagn Ther. 2021 Apr;11(2):602-610. 4. Arnold M, Haug J, Landendinger M. Tricuspid Annuloplasty: Transcatheter Approaches. Curr Cardiol Rep. 2021 Aug 19;23(10):139. 5. Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, Bellmann-Weiler R, Adolf C, Wolf D, Pirklbauer M, Graziadei I, Gänzer H, von Bary C, May AE, Wöll E, von Scheidt W, Rassaf T, Duerschmied D, Brenner C, Kääb S, Metzler B, Joannidis M, Kain HU, Kaiser N, Schwinger R, Witzenbichler B, Alber H, Straube F, Hartmann N, Achenbach S, von Bergwelt-Baildon M, von Stülpnagel L, Schoenherr S, Forer L, Embacher-Aichhorn S, Mansmann U, Rizas KD, Massberg S; ACEI-COVID investigators. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med.2021 Aug;9(8):863-872. 6. Bittner DO, Goeller M, Dey D, Zopf Y, Achenbach S, Marwan M. High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA. Atherosclerosis. 2021 Jan;316:73-78. 7. Boeder NF, Dörr O, Gaderer R, Blachutzik F, Achenbach S, Elsässer A, Hamm C, Nef HM. Clinical presentation does not affect acute mechanical performance of the Novolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography. Postepy Kardiol Interwencyjnej. 2021 Sep;17(3):272-280. 8. Boeder NF, Dörr O, Koepp T, Blachutzik F, Achenbach S, Elsässer A, Hamm CW, Nef HM. Acute mechanical performance of Magmaris vs. DESolve bioresorbable scaffolds in a real-world scenario. Front Cardiovasc Med. 2021 Jun 14;8:696287. 9. Boeder NF, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm CW, Nef HM; GABI-R Study Group. Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy. Catheter Cardiovasc Interv. 2021 Oct;98(4):E555-E563. 10. Carabelli A, Jabeur M, Jacon P, Rinaldi CA, Leclercq C, Rovaris G, Arnold M, Venier S, Neuzil P, Defaye P. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2021 May21;23(5):740-747. 11. Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Borggrefe M, Nienaber CA, Weiß C, Pleger ST, Ince H, Maier J, Achenbach S, Sigusch HH, Hochadel M, Schneider S, Senges J, Akin I. Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry. Clin Res Cardiol. 2021 Jan;110(1):12-20. 12. Foldyna B, Zeleznik R, Eslami P, Mayrhofer T, Scholtz JE, Ferencik M,Bittner DO, Meyersohn NM, Puchner SB, Emami H, Pellikka PA, Aerts HJWL, Douglas PS, Lu MT, Hoffmann U. Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial. Eur Radiol.2021 Aug;31(8):6200-6210. PUBLIKATIONEN
RkJQdWJsaXNoZXIy ODIyMTAw